Notice for sibeprenlimab (Otsuka Australia Pharmaceutical Pty Ltd)
Active ingredients
sibeprenlimab
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
solution for injection
Indication
Treatment of Primary immunoglobulin A Nephropathy (IgAN)
Therapeutic area
Nephrology